期刊文献+

精神分裂症患者及其未发病一级亲属跨期决策的研究 被引量:3

The study of intertemporal decision-making of schizophrenia and their unaffected siblings
下载PDF
导出
摘要 目的探讨精神分裂症患者跨期决策能力是否受损,及其未发病一级亲属是否也存在一定程度上跨期决策能力的受损。方法选取25例精神分裂症患者,25名患者未发病的一级亲属及30名与年龄、教育程度相匹配的健康对照者,采用延迟折扣(Delay-discount)中文版实验范式评价跨期决策能力、成套的神经心理学测试分析三组神经心理学特征。折扣率k值反映跨期决策能力。结果患者组,亲属组及对照组的k值分别为(0.005±0.009),(0.011±0.014),(0.024±0.029),差异有统计学意义(F=9.487,P<0.001);其中患者组与对照组、亲属组与对照组之间差异均有统计学意义(均P<0.05),而患者组与亲属组差异无统计学意义(P>0.05)。k值与一般神经心理学背景测试之间相关性差异均无统计学意义(P>0.05)。结论精神分裂症患者跨期决策能力受损,未发病一级亲属也存在一定程度上跨期决策能力的损伤。 Objective To explore whether the ability of intertemporal choice is impaired in schizophrenic patients and in their unaffected siblings. Methods Twenty-five schizophrenia patients, twenty-five unaffected siblings of patients and thirty healthy controls were recruited in the study. "Delay-discounting" task and a battery of cognitive neuropsychological assessment were used to examine the intertemporal decision-making. Results(1) the value of k was((0.005 ±0.009 in schizophrenia, 0.011 ±0.014 in unaffected siblings and 0.024 ±0.029 in healthy controls, respectively.There was significant difference in k value among these three groups(F =9.487, P〈0.001). There were significant differences in k value between patients group and healthy controls, and between unaffected siblings and healthy controls(P〈0.05). There was no significant difference between schizophrenia and their unaffected siblings(P〈0.05).(2) Pearson correlation analysis not showed any relationship between neuropsychological test and the value of k. Conclusion The ability of intertemporal choices is impaired in schizophrenia and their unaffected siblings to a great degree.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2017年第8期470-474,共5页 Chinese Journal of Nervous and Mental Diseases
基金 国家自然科学基金(编号:31571149) 国家自然科学基金青年基金项目(编号:81300944) 国家自然基金面上项目(编号:81171273)
关键词 精神分裂症 跨期决策 延迟折扣 一级亲属 Schizophrenia Intertemporal choice Delay-discount Siblings
  • 相关文献

参考文献2

二级参考文献31

  • 1Lieberman JA. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J Clin Psychiatry,1999; 60 [Suppl, 12]: 9-12.
  • 2Flashman LA, Green MF. Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effect of treatment. Psychiat Clin North Am, 2004, 27 (1): 1-18.
  • 3Rund BR, Melh I, Ffiis S, et al. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry, 2004, 161: 466-472.
  • 4Ragland JD, Gur RC, Valdez J, et al. Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry, 2004, 161: 1004-1015.
  • 5James AC, James S, Smith DM. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescentonsel schizophrenia. Am J Psychiatry, 2004, 161: 1023-1029.
  • 6Harvey PD. Cognitive functioning in late-life schizophrenia: its importance and implications for overall outcome. J Clin Psychiatry, 1999, 60 [Suppl, 13]: 10-16.
  • 7Friedman JI, Temporini H, Davis KL. Pharmacologic strategies for augmenting cogitive performance in schizophrenia. Biol Psychiatry, 1999, 45 (1): 1-16.
  • 8Tamminga C. Clutamatergic aspects of schizophrenia. Br J Psychiatry, 1999, 174 [Suppl, 37]: 12-15.
  • 9Carlsson A, Hansson LO, Waters N, et al. A glutamatergic deficiency model of schizophrenia. Br J Psychiatry, 1999, 174.[Suppl, 37] : 2-6.
  • 10Keefe RS, Seidman LJ, Christensen BK. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychotics: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry, 2004, 161: 985-995.

共引文献34

同被引文献17

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部